Sibannac, Inc. (SNNC) Announces Joint Venture With 1120 Management, LLC to Develop State-of-the-Art DEA-Compliant Psilocybin Research Facility in Phoenix, Arizona
Sibannac, Inc. has signed a Letter of Intent to form a joint venture with 1120 Management, LLC, an Arizona-based licensed medical cannabis operator. The joint venture will develop a state-of-the-art, DEA-compliant psilocybin research facility in Phoenix, Arizona, with a focus on advanced cultivation, extraction, and preclinical studies. 1120 Management will contribute dedicated space, capital, and infrastructure support, while Sibannac will provide scientific and operational expertise.
Key figures
- Power supply
- 3,000 Amps of 480V 3-phase power
- Facility size
- 30,000-square-foot
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.